Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

273.00
Delayed Data
As of Aug 07
 -0.35 / -0.13%
Today’s Change
165.23
Today|||52-Week Range
306.08
+24.69%
Year-to-Date
Vertex Pharmaceuticals Incorporated 2020 Q2 - Results - Earnings Call Presentation
Jul 31 / Seeking Alpha - Paid Partner Content
Vertex posts strong Q2 on robust Trikafta sales
Jul 30 / Seeking Alpha - Paid Partner Content
Wall Street Breakfast: Big Beats From Big Tech
Jul 31 / Seeking Alpha - Paid Partner Content
Vertex Pharmaceuticals EPS beats by $0.53, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
How Vertex Pharmaceuticals Wowed With Its Q2 Results
Jul 31 / MotleyFool.com - Paid Partner Content
Vertex Pharmaceuticals Q2 2020 Earnings Preview
Jul 29 / Seeking Alpha - Paid Partner Content
Vertex Pharmaceuticals Inc (VRTX) Q2 2020 Earnings Call Transcript
Jul 31 / MotleyFool.com - Paid Partner Content
Notable earnings after Thursday's close
Jul 29 / Seeking Alpha - Paid Partner Content
Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q2 2020 Results - Earnings Call Transcript
Jul 30 / Seeking Alpha - Paid Partner Content
Getting Your Spouse on Board With Your New Investing Obsession
Jul 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close273.34
Today’s open273.48
Day’s range269.95 - 277.20
Volume1,005,983
Average volume (3 months)1,885,363
Market cap$71.1B
Data as of 3:59pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)-44.37%
Earnings growth (this year)+81.63%
Earnings growth (next 5 years)+46.50%
Revenue growth (last year)+35.47%
P/E ratio34.5
Price/Sales13.82
Price/Book11.62

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.08-0.05%
REGNRegeneron Pharmaceut...-1.00-0.16%
----
----
Data as of 4:00pm ET, 08/07/2020

Financials

Next reporting dateOctober 21, 2020
EPS forecast (this quarter)$2.28
Annual revenue (last year)$4.1B
Annual profit (last year)$1.2B
Net profit margin28.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts